相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer Post Hoc Analysis of the CLASSIC Randomized Controlled study
Yoon Young Choi et al.
ANNALS OF SURGERY (2019)
Identification of a novel cell cycle-related gene signature predicting survival in patients with gastric cancer
Lan Zhao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Dongqiang Zeng et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Characterization of the prognostic values of CXCR family in gastric cancer
Chaoran Yu et al.
CYTOKINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients
Xin Ji et al.
GASTRIC CANCER (2018)
Gene expression profiles for a prognostic immunoscore in gastric cancer
D. Zeng et al.
BRITISH JOURNAL OF SURGERY (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
ImmunoScore Signature A Prognostic and Predictive Tool in Gastric Cancer
Yuming Jiang et al.
ANNALS OF SURGERY (2018)
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
Elizabeth D. Thompson et al.
GUT (2017)
MS4A4A: a novel cell surface marker for M2 macrophages and plasma cells
Ratna Sanyal et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma
C. Zhu et al.
ONCOGENE (2017)
A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
Ti Wen et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Tumor infiltration by Tbet plus effector T cells and CD20+B cells is associated with survival in gastric cancer patients
Audrey Hennequin et al.
ONCOIMMUNOLOGY (2016)
Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer
Alessandra Metelli et al.
CANCER RESEARCH (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee
Tetsuji Sawada et al.
GASTRIC CANCER (2015)
Robust Likelihood-Based Survival Modeling with Microarray Data
HyungJun Cho et al.
Journal of Statistical Software (2015)
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Sung Hoon Noh et al.
LANCET ONCOLOGY (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Gastric Cancer Working Group Report
Mitsuru Sasako et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3(+) T cells in lymphocyte-rich gastric carcinoma
H. Ohtani et al.
JOURNAL OF PATHOLOGY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
